Plain-English translation of NCT06269536 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a stress-reducing breathing technique called heart-rate variability biofeedback can help people with muscle-invasive bladder cancer feel better during their chemotherapy treatment. You would learn deep, paced breathing exercises guided by a heart-rate monitor, and practice them at home for three months alongside your standard cancer treatment. Researchers want to see if this breathing program reduces inflammation, improves sleep, helps with thinking clearly, and makes chemotherapy easier to tolerate.
Chemotherapy for bladder cancer is very tough on the body and mind—it causes stress, pain, and side effects that can hurt quality of life. This trial exists to find out whether a simple, low-cost breathing technique can help your body handle treatment better and may even improve how well the treatment works.
You likely qualify if…
You likely don't qualify if…
You would receive standard chemotherapy (one of two combinations given over 3–4 courses) followed by surgery or radiation, just like anyone with your diagnosis. In addition, you would meet with a breathing trainer 4 times to learn a deep paced breathing technique, then practice it at home three times a day for 7 minutes each for 3 months using an online program to track your progress. Throughout the study, researchers would measure your stress levels, sleep quality, thinking ability, and how well you tolerate treatment compared to patients receiving standard care alone.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Slovakia
Sponsor
Comenius University
Enrollment target
~50 participants
Started
February 2024
Primary completion
February 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Luba Hunáková
Faculty of Medicine, Comenius University in Bratislava
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.